Full text is available at the source.
Impact of formulation and process parameters on the stability and bioactivity of RNA-loaded lipid nanoparticles during nebulization
How formulation and processing affect the stability and function of RNA lipid nanoparticles during aerosol delivery
AI simplified
Abstract
siRNA lipid nanoparticles (LNPs) maintained RNA integrity and biological function after nebulization, while mRNA LNPs showed degradation.
- LNPs are commonly used as RNA carriers, primarily administered through injections.
- Inhalation of LNPs may offer benefits due to the lung's large surface area and low degradation environment.
- Nebulization can introduce thermal and mechanical stress that affects LNP properties.
- Formulation variables, such as temperature and buffer type, influence the stability and effectiveness of LNPs.
- siRNA LNPs demonstrated the ability to protect encapsulated RNA from degradation, preserving their biological activity.
- mRNA LNPs experienced cargo degradation and loss of biological function post-nebulization, likely due to their higher sensitivity.
AI simplified